Explore Data PULSE, a platform which helps you to navigate the complex landscape of data, regulatory and IP protection concerns at each stage of the medical product life cycle. As you navigate through each key issue, Data PULSE will help you to identify and mitigate risks across multiple jurisdictions and optimize your strategy through research, market authorization and post-market study phases.

The new Clinical Trials Regulation became applicable on 31 January 2022, following achievement of the full functionality by the new Clinical Trials Information System, bringing more transparency into the area of clinical trials.

The Health Pod, Baker McKenzie’s industry podcast series, highlights sector-specific issues and trends that affect healthcare and life sciences companies. Episode 5: Japan Pharmaceuticals Market – Distinguishing Features and Industry Practice Japan accounts for approximately 7% of the global pharmaceuticals market and is the third-largest market in the world following…

The Health Pod, Baker McKenzie’s industry podcast series, highlights sector-specific issues and trends that affect healthcare and life sciences companies. Episode 5: Japan Pharmaceuticals Market – Distinguishing Features and Industry Practice Japan accounts for approximately 7% of the global pharmaceuticals market and is the third-largest market in the world following…

With the healthcare and life sciences sector at the heart of the pandemic, we are seeing some new issues arising in the already complex world of life sciences collaborations, for both coronavirus-related and other products and therapies. The Life Sciences Collaborations: Key Considerations in the COVID-19 Era document is a…

Read publication  Welcome to the October 2019 edition of our newsletter. The EMEA Healthcare Industry Group Newsletter is your regular digest of legal developments affecting the life science and healthcare industries across the region. In this issue: Europe • General presumption of confidentiality of clinical study reports: Opinion of AG…

Read publication Welcome to the July 2019 edition of our newsletter. The EMEA Healthcare Industry Group Newsletter is your regular digest of legal developments affecting the life science and healthcare industries across the region. In this Issue: Europe New EU measures boost the generic pharmaceuticals industry Falsified drugs from Italy…

On 6 February 2019, Federal Law No. 2 of 2019 was enacted in the UAE, which will regulate the collection, processing and transfer of electronic health data and may significantly impact healthcare service providers and life sciences companies operating locally. Cloud-based health solutions which collect, store and process health data…

We are pleased to invite you to our workshop on “Managing Risk: Compliance in the Healthcare Sector in the Middle East” that will take place in our offices in Dubai on February 26, 2018.